Tiomesterone

Testicular Microlithiasis is a medical condition characterized by the presence of small, non-shadowing echogenic foci within the parenchyma of the testis without acoustic shadowing. These foci are typically less than 3 mm in size.

Epidemiology

Testicular microlithiasis is seen in approximately 2.4-5.6% of men who undergo scrotal ultrasound for various reasons. The condition is often bilateral and is associated with certain genetic syndromes, such as Peutz-Jeghers syndrome and Down syndrome.

Clinical Presentation

Most patients with testicular microlithiasis are asymptomatic and the condition is often discovered incidentally during scrotal ultrasound for other reasons. Some patients may present with testicular pain or discomfort.

Diagnosis

The diagnosis of testicular microlithiasis is made by ultrasound examination of the scrotum. The characteristic ultrasound finding is multiple, tiny, non-shadowing echogenic foci scattered throughout the testicular parenchyma.

Management

The management of testicular microlithiasis is controversial. Some experts recommend regular follow-up with scrotal ultrasound, while others believe that routine follow-up is not necessary unless the patient has other risk factors for testicular cancer.

Prognosis

The prognosis of testicular microlithiasis is generally good. However, there is some evidence to suggest that the condition may be associated with an increased risk of testicular cancer.

See Also

• Testicular cancer
• Scrotal ultrasound
• Peutz-Jeghers syndrome
• Down syndrome

References

Tiomesterone Resources
Latest articles Most recent articles Ongoing trials	Wikipedia